Skip to main content

Table 3 Psychometric validation: demographics characteristics of the study population

From: Development and validation of Gaucher disease type 1 (GD1)-specific patient-reported outcome measures (PROMs) for clinical monitoring and for clinical trials

  Main sample
(N = 46)
Test–retest sample
(n = 23)
Characteristic n % n %
Age, years
 2534 9 19.6 4 17.4
 3544 13 28.3 6 26.1
 4554 3 6.5 1 4.3
 5564 12 26.1 5 21.7
 6574 5 10.9 5 21.7
 ≥75 4 8.7 2 8.7
Gender
 Male 23 50.0 10 43.5
 Female 22 47.8 12 52.2
 Missing 1 2.2 1 4.3
Ethnicity
 White 45 97.8 22 95.7
 Other 1 2.2 1 4.3
Occupational status
 Employed part-time 8 17.4 3 13.0
 Employed full-time 14 30.4 6 26.1
 Self-employed 4 8.7 1 4.3
 Unemployed 5 10.9 2 8.7
 Retired 13 28.3 9 39.1
 Missing 2 4.3 2 8.7
Time since diagnosis
 <1 year 2 4.3 0 0.0
 14 years 3 6.5 1 4.3
 59 years 5 10.9 4 17.4
 1019 years 6 13.0 2 8.7
 ≥20 years 29 63.0 16 69.6
 Missing 1 2.2 0 0.0
Current health
 Very good 7 15.2 4 17.4
 Good 20 43.5 9 39.1
 Fair 13 28.3 6 26.1
 Bad 4 8.7 3 13.0
 Very bad 2 4.3 1 4.3
Gaucher disease severity state
 Mild (GD1-DS3 score < 3.00) 21 45.7 12 52.2
 Moderate (GD1-DS3 score 3.005.99) 7 15.2 2 8.7
 Marked (GD1-DS3 score 6.008.99) 11 23.9 3 13.0
 Severe (GD1-DS3 score 9.0019.00) 7 15.2 6 26.1
  1. GD1-DS3 Gaucher disease type 1- disease severity scoring system (three domains)